Global Dengue Vaccine Market Share Report 2024, Forecast To 2033
7 Nov, 2024
The dengue vaccine market size has seen rapid growth in recent years, with expectations to rise from $0.57 billion in 2023 to $0.64 billion in 2024, at a compound annual growth rate (CAGR) of 12.0%. This growth in the historical period can be linked to increased travel and urbanization, heightened demand for effective vaccines, rising incidence of foreign travel exposure, expanded healthcare services, and an increase in mass vaccinations. Looking forward, the dengue vaccine market is anticipated to grow to $1.02 billion in 2028, with a CAGR of 12.3%. This growth is driven by the rising incidence of dengue, initiatives from various organizations, a growing number of clinical trials, and a focus on developing multi-strain and tetravalent vaccine formulations. Key trends during this period include a growing demand for preventive vaccines, advancements in vaccine technology, the development of combination vaccines, increased research and clinical trials for new vaccine candidates, and efforts to improve vaccine efficacy and safety profiles.
Global Dengue Vaccine Market Key Driver
The rising number of dengue fever cases is expected to propel the growth of the dengue vaccine market going forward. Dengue fever is a viral infection spread by Aedes aegypti mosquitoes, causing high fever, headaches, joint pain, and rashes. The rise in dengue fever cases is attributed to climate change, urbanization, inadequate mosquito control, and viral evolution. The dengue vaccine activates the immune system to identify and combat the dengue virus, reducing infection severity and decreasing the risk of severe complications, thereby helping to lower cases and hospitalizations. For instance, in May 2024, the World Health Organization reported that dengue cases in the American region surpassed 7 million in April 2024, an increase from 4.6 million cases reported in 2023. Therefore, the rising number of dengue fever cases is driving the growth of the dengue vaccine market, projected to reach USD 1 billion by 2024 and grow to USD 1.5 billion by 2028.
Get A Free Sample Of The Dengue Vaccine Market ReportGlobal Dengue Vaccine Market Segments
The dengue vaccine market covered in this report is segmented –
1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I, Phase II, Phase III
3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users
By Geography:The regions covered in the dengue vaccine market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Asia-Pacific was the largest region in the dengue vaccine market in 2023. North America is expected to be the fastest-growing region in the forecast period.
Major Dengue Vaccine Industry Players
Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Sun Pharmaceutical Industries Ltd., Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.
Purchase The Global Dengue Vaccine Market Report Directly And Get A Swift Delivery
Dengue Vaccine Market Overview
A dengue vaccine is a biological preparation designed to prevent dengue fever, a mosquito-borne viral disease caused by the dengue virus (DENV). If exposed in the future, dengue vaccines stimulate the body's immune system to recognize and fight off the dengue virus.
Dengue Vaccine Global Market Report 2023 provides data on the global dengue vaccine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The dengue vaccine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.